# Nordicus Partners Corporation (NORD)

Source: https://www.quantisnow.com/company/NORD
Generated: 2026-11-18T09:01:05.454Z

- Ticker: NORD
- Exchange: NASDAQ
- Sector: Consumer Discretionary
- Industry: Professional Services
- SEC CIK: 0001011060

## About

Nordicus Partners Corporation is a U.S. based company focusing on acquiring and developing drugs from innovative biotech companies in the Nordics, a region known for its brilliant scientists, exceptional life science ecosystem and drug discoveries and developments. Nordicus is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs - starting with oral disorders. Its scientific foundation targets inflammation and immune modulation. In 2024, Nordicus acquired 100% of Orocidin A/S, a Danish preclinical-stage biotech company developing next-generation therapies for periodontitis and 100% of Bio-Convert A/S, a Danish preclinical-stage biotech company dedicated to revolutionizing the treatment of oral leukoplakia.

## Latest NORD news and filings

- 2026-11-13 21:05 UTC [SEC Form NT 10-Q filed by Nordicus Partners Corporation](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-nordicus-partners-corporation-6790480)
- 2026-11-12 11:15 UTC [Insider Buy] [Director Ac Nordic Aps bought $40,000 worth of shares (20,000 units at $2.00), increasing direct ownership by 0.64% to 3,139,335 units (SEC Form 4)](https://www.quantisnow.com/insight/director-ac-nordic-aps-bought-40000-worth-of-shares-20000-6785823)
- 2026-11-11 01:38 UTC [SEC Form 4] [Chief Financial Officer Yankowitz Bennett J. was granted 1,000,000 stock options (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-yankowitz-bennett-j-was-granted-1000000-stock-6785010)
- 2026-11-11 01:36 UTC [SEC Form 4] [Chief Executive Officer Rouf Henrik was granted 2,000,000 stock options (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-rouf-henrik-was-granted-2000000-stock-options-6785008)
- 2026-11-10 21:30 UTC [SEC Form 8-K] [Nordicus Partners Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nordicus-partners-corporation-filed-sec-form-8-k-entry-into-a-6784393)
- 2026-11-04 21:05 UTC [SEC Form 8-K] [Nordicus Partners Corporation filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/nordicus-partners-corporation-filed-sec-form-8-k-unregistered-sales-of-6772457)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NORD
- Earnings history: https://www.quantisnow.com/earnings/NORD
- Dividend history: https://www.quantisnow.com/dividends/NORD
- Insider transactions: https://www.quantisnow.com/insiders/NORD
- Options chain: https://www.quantisnow.com/options/NORD
- SEC 8-K filings only: https://www.quantisnow.com/company/NORD/8-k
- RSS and alerts for NORD: https://www.quantisnow.com/docs/rss-feeds.md
